United States · FDA National Drug Code directory

CONSTIPATION CP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43406-0057_384d29dc-dfcd-445d-acf8-d00397950a18
Product NDC
43406-0057
Form
LIQUID
Composition / generic term
Aluminum Oxide, Bryonia Alba Root, Matricaria Recutita, Graphite, Lycopodium Clavatum Spore, Strychnos Nux-Vomica Seed, Silicon Dioxide, Sulfur, Sodium Chloride, Magnesium Chloride, Lead, Sepia Officinalis Juice.
Labeler
Natural Creations, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20100101
Source listing expiry
20261231

Source-listed ingredients

  • ALUMINUM OXIDE — 30 [hp_C]/mL
  • BRYONIA ALBA ROOT — 30 [hp_C]/mL
  • MATRICARIA RECUTITA — 30 [hp_C]/mL
  • GRAPHITE — 30 [hp_C]/mL
  • LYCOPODIUM CLAVATUM SPORE — 30 [hp_C]/mL
  • STRYCHNOS NUX-VOMICA SEED — 30 [hp_C]/mL
  • SILICON DIOXIDE — 30 [hp_C]/mL
  • SULFUR — 30 [hp_C]/mL
  • SODIUM CHLORIDE — 30 [hp_C]/mL
  • MAGNESIUM CHLORIDE — 30 [hp_C]/mL
  • LEAD — 30 [hp_C]/mL
  • SEPIA OFFICINALIS JUICE — 30 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (43406-0057-1) · 43406-0057-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
CONSTIPATION CP — United States | Molindra Medicines